Factual end-of-day data for NEULANDLAB: price and volume, delivery percentage, 52-week position, indicator levels and intraday order flow. Refreshed after every NSE session.
Traded volume of 46,754 shares was well below the 20-day average (0.4×).
NEULANDLAB's delivery share of 50.1% was above its 20-day average of 42.8%.
Intraday order-flow data from VolumeLens tick classification — the running difference between aggressive buying and selling volume. This dataset is not published by any other Indian platform.
| Indicator | Reading (26 Aug 2026) |
|---|---|
| RSI (14) | 67.4 |
| 50-day EMA | ₹20,390.71 — close is above |
| 200-day EMA | ₹17,059.36 — close is above |
| SuperTrend (10, 3) | ₹21,510.00 — close is above the line |
Indicator values are computed from adjusted daily closes and describe where price sits relative to each level — they are statistics, not signals.
NEULANDLAB is a large-cap NSE stock in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry), with a market capitalisation of about ₹20,653 crore.
Footprint chart, DOM ladder, cumulative delta and volume profile — free to explore.
On 26 Aug 2026, 50.1% of NEULANDLAB's traded volume was marked for delivery (23,436 shares delivered). The 20-day average delivery is 42.8%.
NEULANDLAB closed at ₹23,545.00 on 26 Aug 2026 (+2.60% vs the previous close).
52-week high ₹23,881.00, 52-week low ₹11,500.00. The latest close is -1.41% from the 52-week high.